Published in
American Association for the Advancement of Science, Science Translational Medicine, 461(10), 2018
DOI: 10.1126/scitranslmed.aat1445
Links
Tools
p95HER2–T cell bispecific antibody for breast cancer treatment
Journal article published in 2018 by
Irene Rius Ruiz 
,
Rocio Vicario ,
Beatriz Morancho ,
Cristina Bernadó Morales,
Enrique J. Arenas ,
Sylvia Herter,
Anne Freimoser-Grundschober ,
Jitka Somandin,
Johannes Sam,
Oliver Ast ,
Águeda Martinez Barriocanal ,
Antonio Luque ,
Marta Escorihuela,
Ismael Varela ,
Isabel Cuartas
and other authors.
,
Rocio Vicario ,
Beatriz Morancho ,
Cristina Bernadó Morales,
Enrique J. Arenas ,
Sylvia Herter,
Anne Freimoser-Grundschober ,
Jitka Somandin,
Johannes Sam,
Oliver Ast ,
Águeda Martinez Barriocanal ,
Antonio Luque ,
Marta Escorihuela,
Ismael Varela ,
Isabel Cuartas
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
T cell bispecific antibodies against an isoform of HER2 effectively target many HER2-expressing tumors but not normal tissues.